CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
Phase I clinical trial for the evaluation of the therapeutic vaccine candidate Terap C.	2010-06-11	Registered
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers.	2010-12-24	Registered
Clinical trial, phase II, to evaluate rhEGF efficacy and safety at a dose of 25 or 75 micrograms intralesionally in patients with diabetic foot ulcer (Wagner grade 1 or 2).	2010-12-24	Registered
InCroMiel I	2009-12-24	Registered
InCCNM -I	2010-12-24	Registered
CITOPROT-III	2009-02-26	Registered
Application of CIGB-128 in keloid patients undergoing surgical exeresis.	2010-12-24	Registered
CIGB-128 administration to patients with surgically-treated keloids.	2010-12-24	Registered
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed	2010-12-27	Registered
FASECU I	2008-10-16	Registered
InCarbacel-II	2010-12-28	Registered
Recombinant interferon alpha-2b in paranoid schizophrenia.	2009-02-11	Registered
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis.	2009-02-11	Registered
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C.	2009-02-11	Registered
THERESA-3 Study	2009-12-11	Registered
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency.	2010-09-27	Registered
Diphenhydramine previous to CIGB-300 in cervical carcinoma (CERVISEG-II Study)	2013-05-16	Registered
CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study)	2013-06-06	Registered
Interferon Combination in basal cell carcinoma (InCarbacel-IV study)	22/08/2013	Registered
VISION Study	26/10/2021	Registered

Registered Trials

Registration process

CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

About the RPCEC

Useful resources